UroGen Pharma URGN Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$23.57M+10.6% | -$26.36M+20.9% | -$33.35M+33.2% | -$49.94M-13.9% | -$43.84M-16.9% | ||
| $75K0.0% | $75K-25.0% | $100K0.0% | $100K+38.9% | $72K+5.9% | ||
| $4.63M+47.8% | $3.13M+3.4% | $3.03M+10.8% | $2.73M-10.9% | $3.07M-7.1% | ||
| -$45.32M-18.2% | -$38.33M+9.3% | -$42.27M-6.1% | -$39.83M+5.2% | -$42.02M-209% | ||
| $54K+218% | $17K-80.5% | $87K-38.3% | $141K+220% | $44K-61.7% | ||
| -$20.69M-175% | $27.72M-11.7% | $31.4M+10.5% | $28.41M+209% | -$25.96M— | ||
| $65.35M— | $0— | —— | —— | $0-100% | ||
| $65.2M+108% | $31.32M+279% | $8.27M+2,695% | $296K+771% | $34K-52.1% | ||
| -$800K— | —— | -$2.6M+76.6% | -$11.12M+83.6% | -$67.95M-244% | ||
| -$45.37M-18.3% | -$38.34M+9.5% | -$42.36M-6.0% | -$39.97M+5.0% | -$42.07M-206% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does UroGen Pharma's cash flow data come from?
- Every line is extracted from UroGen Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.